Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

Health Canada approves BRILINTA (ticagrelor tablets)
1 June 2011
AstraZeneca signs agreement in Japan with Daiichi Sankyo to co-promote denosumab for cancer
24 May 2011
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
9 May 2011
AstraZeneca PLC First Quarter Results 2011
28 April 2011
FDA approves orphan drug vandetanib
7 April 2011
UK and US governments reach agreement over AstraZeneca tax matters
28 March 2011
AstraZeneca initiates phase III clinical programme evaluating NKTR-118 for treatment of opioid-induced constipation
15 March 2011
FDA accepts new drug application for investigational compound Dapagliflozin for the treatment of type 2 diabetes
8 March 2011
AstraZeneca to discontinue production of PULMICORT® pMDI, other respiratory medicines not affected
7 March 2011
Onglyza becomes the first DPP4 inhibitor available for use in Europe in Type 2 Diabetes patients with moderate or severe renal impairment
4 March 2011

<
1
2
3
111
>

All of our latest press releases and articles are available to explore